Ventricular tachycardia/ventricular fibrillation ablation in the setting of ischemic heart disease.

Abstract

Recurrent ventricular tachycardia (VT) in the setting of coronary artery disease is frequently a life-threatening electrophysiologic emergency. Even in patients with an implantable defibrillator, recurrent VT is frequently accompanied by repeated and disabling shock therapy. Catheter ablative therapy offers the ability to provide immediate control of recurrent VT. Long-term elimination of VT should be anticipated in most patients. This article reviews the strategies, tools, techniques, and expected outcome for catheter ablation of stable and unstable ventricular arrhythmias in the setting ischemic heart disease.

• Authors: Francis Marchlinski, Fermin Garcia, Amir Siadatan, William Sauer, Stuart Beldner, Erica Zado, Henry Hsia, David Lin, Joshua Cooper, Ralph Verdino, Edward Gerstenfeld, Sanjay Dixit, Andrea Russo, David Callans
• Journal: Journal of cardiovascular electrophysiology (J Cardiovasc Electrophysiol) Vol. 16 Suppl 1 Pg. S59-70 (Sep 2005) ISSN: 1045-3873 [Print] United States
• PMID: 16138888 (Publication Type: Journal Article)

Topics

• Catheter Ablation (methods)
• Humans
• Myocardial Ischemia (complications, surgery)
• Practice Guidelines as Topic
• Practice Patterns, Physicians'
• Secondary Prevention
• Tachycardia, Ventricular (etiology, prevention & control)
• Treatment Outcome
• Ventricular Fibrillation (etiology, prevention & control)